• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS Back to Search Results
Model Number DB-2202-45
Device Problem Unintended Movement (3026)
Patient Problems Nausea (1970); Blurred Vision (2137); Visual Disturbances (2140)
Event Date 05/11/2021
Event Type  Injury  
Event Description
It was reported that during a stage i deep brain stimulator (dbs) implant procedure, the physician inserted the lead beyond the intended target; and as a result, in the patient experienced symptoms of nausea and blurred vision.The physician reinserted the lead at the intended target, and the procedure concluded without further incident.Post-operatively magnetic resonance imaging (mri) revealed the lead was well positioned, and the patient experienced relief from the aforementioned symptoms.A week later, the patient successfully completed the stage ii procedure, but reported double vision and difficulty tracking with her left eye.No further information has been obtained despite good faith efforts.
 
Event Description
It was reported that during a stage i deep brain stimulator (dbs) implant procedure, the physician inserted the lead beyond the intended target; and as a result, in the patient experienced symptoms of nausea and blurred vision.The physician reinserted the lead at the intended target, and the procedure concluded without further incident.Post-operatively magnetic resonance imaging (mri) revealed the lead was well positioned, and the patient experienced relief from the aforementioned symptoms.A week later, the patient successfully completed the stage ii procedure, but reported double vision and difficulty tracking with her left eye.No further information has been obtained despite good faith efforts.Additional information received stated the physician assessed the patient's double vision was caused by swelling of the cranial nerve iii and her vision would continue to improve and resolve.No further action has been scheduled.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE CARTESIA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
MDR Report Key11924329
MDR Text Key254054749
Report Number3006630150-2021-02615
Device Sequence Number1
Product Code NHL
UDI-Device Identifier08714729905288
UDI-Public08714729905288
Combination Product (y/n)N
PMA/PMN Number
P150031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 06/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date01/15/2023
Device Model NumberDB-2202-45
Device Catalogue NumberDB-2202-45
Device Lot Number7079427
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/11/2021
Initial Date FDA Received06/02/2021
Supplement Dates Manufacturer Received06/18/2021
Supplement Dates FDA Received06/25/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age54 YR
-
-